vimarsana.com

Latest Breaking News On - Ambre delval - Page 2 : vimarsana.com

TheraVet Signs an Important Distribution Agreement With the Orthopaedics & Surgical Instrumentation

Distribution agreement for the new BIOCERA-VET® product line including Bone Surgery - Ready to Use, Osteosarcoma Ready to Use, Granules & Smartgraft - in United Kingdom and IrelandKey marketing and sales support for the upcoming commercial launch of these products in United Kingdom and IrelandGOSSELIES, Wallonia, Be.

United-kingdom
Ireland
Paris
France-general
France
Brussels
Bruxelles-capitale
Belgium
Texas
United-states
Gosselies
Waals-gewest

Spartoo Announces the Availability of Its 2021 Annual Financial Report and Its Financial Calendar For 2022

Regulatory News: Spartoo (ISIN: FR00140043Y1 ticker: ALSPT) (Paris:ALSPT), one of the leading online retailers for fashion items in Europe, today announced the availability to the public and the

Paris
France-general
France
Nicolas-fossiez
Louis-victor-delouvrier
Ambre-delval
Regulatory-news
Financial-reports
Gross-merchandise-value
Merchandise-value
Victor-delouvrier

Spartoo Voted best Online Retailer, for the Second Time, in the 2022 Ranking of Capital Magazine

Regulatory News: Spartoo (ISIN: FR00140043Y1 ticker: ALSPT) (Paris:ALSPT), one of the leading online retailers for fashion items in Europe, today announced that it has been ranked number one in

Paris
France-general
France
Boris-saragaglia
Nicolas-fossiez
Louis-victor-delouvrier
Ambre-delval
Regulatory-news
Gross-merchandise-value
Victor-delouvrier
Spartoo

TheraVet Reports Full Year 2021 Financial Results and Confirms Its Ambitious Development and Commercial Plans for 2022

Positive safety and efficacy results for BIOCERA-VET (arthrodesis and canine osteosarcoma) and VISCO-VET (canine osteoarthritis) Initiation of the pivotal European multicentric clinical study

Germany
United-states
Paris
France-general
France
Netherlands
United-kingdom
Texas
Belgium
Portugal
Ireland
Poland

TheraVet Reports Full Year 2021 Financial Results and Confirms Its Ambitious Development and Commerc

Positive safety and efficacy results for BIOCERA-VET® (arthrodesis and canine osteosarcoma) and VISCO-VET® (canine osteoarthritis)Initiation of the pivotal European multicentric clinical study evaluating VISCO-VET® in canine osteoarthritisCommercialization of BIOCERA-VET® Bone Surgery and BIOCERA-VET® Osteosarcoma i.

Germany
United-states
Paris
France-general
France
Netherlands
United-kingdom
Texas
Wallonia
Waals-gewest
Belgium
Portugal

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.